ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 1187

$591K Total Retail Price of All Prescriptions

Rank: 129 out of 1187

352 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,415 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METFORMIN HCL 450 365 1 7
AMLODIPINE BESYLATE 436 363 2 2
OMEPRAZOLE 311 243 3 5
SIMVASTATIN 262 228 4 1
LEVOTHYROXINE SODIUM 258 195 5 3
CRESTOR 255 198 6 16
ZOLPIDEM TARTRATE 229 196 7 14
LOVAZA 225 156 8 53
NEXIUM 212 193 9 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 139 10 39
RAMIPRIL 187 146 11 36
CARVEDILOL 175 137 12 19
GLIMEPIRIDE 173 155 13 30
JANUVIA 154 125 14 34
NAPROXEN 148 123 15 72
ALENDRONATE SODIUM 146 125 16 25
LOSARTAN-HYDROCHLOROTHIAZIDE 142 127 17 56
DIOVAN 132 122 18 17
METOPROLOL SUCCINATE 131 111 19 11
LOSARTAN POTASSIUM 123 109 20 21
IBUPROFEN 123 90 20 59
CLOPIDOGREL 123 112 20 33
TRICOR 115 84 23 94
PLAVIX 114 99 24 52
ADVAIR DISKUS 96 67 25 35
LISINOPRIL 94 87 26 4
AZITHROMYCIN 90 77 27 24
ACTOS 88 82 28 101
FLUTICASONE PROPIONATE 85 65 29 31
FUROSEMIDE 81 64 30 8
DIOVAN HCT 74 62 31 40
FENOFIBRATE 73 51 32 88
ATORVASTATIN CALCIUM 71 48 33 6
FAMOTIDINE 71 65 33 48
TAMSULOSIN HCL 70 70 35 29
ATENOLOL 70 56 35 18
HYDROCHLOROTHIAZIDE 65 62 37 9
ENALAPRIL MALEATE 63 58 38 27
SERTRALINE HCL 62 46 39 22
LANTUS SOLOSTAR 60 56 40 92
CITALOPRAM HBR 58 58 41 45
LIDODERM 57 41 42 80
MELOXICAM 57 40 42 49
MECLIZINE HCL 56 56 44 112
SINGULAIR 53 29 45 67
CLOTRIMAZOLE-BETAMETHASONE 52 37 46 100
GLIPIZIDE 51 38 47 71
CELEBREX 51 43 47 68
MONTELUKAST SODIUM 50 33 49 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.